Video modal
popup modal
The MHICC is now Seriant !
The Montreal Health Innovations Coordinating Center (MHICC) is now Seriant.
Our new name reflects a bold step forward— expanding beyond cardiology and embracing innovations in clinical trials with a global reach.
While our identity has evolved, our commitment to operational excellence, client satisfaction, and quality remains the same.
Precision medicine: Progress, challenges, and the path forward
September 18, 2025
Clinical development is costly, complex, and too often derailed when therapies don’t deliver. Precision medicine offers strategies to improve outcomes and safeguard investment.
Recent research shows that drug targets supported by genetics are 2.6× more likely to succeed in clinical development. In 2024, 38% of FDA approvals were personalized medicines, reflecting how precision strategies are driving real-world adoption.
This white paper delivers expert insights and the latest perspectives on progress, challenges, and the path forward for precision medicine trials.
Featured insights:
- Deploying precision medicine across the lifecycle
- Operationalizing precision medicine
- Case studies from large-scale global trials
- Key challenges and strategies for implementation
⬇️ Download now to explore how precision medicine can reduce risk and unlock new potential in clinical development.
